lmb-100
Showing 1 - 8 of 8
Malignant Pleural Mesotheliomas (Mpm), Malignant Pleural Effusions (Mpe), Epithelial Tumors, Malignant Trial run by the National
Not yet recruiting
- Malignant Pleural Mesotheliomas (Mpm)
- +4 more
- Cytoreductive surgery
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Mesothelioma Trial run by the National Cancer Institute (NCI) (LMB-100, nab-paclitaxel)
Completed
- Mesothelioma
- LMB-100
- nab-paclitaxel
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 28, 2022
Mesothelioma Trial run by the National Cancer Institute (NCI) (LMB-100, ipilimumab)
Recruiting
- Mesothelioma
- LMB-100
- ipilimumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
Lung Cancer, Non Small Cell Lung Cancer, Adenocarcinoma of Lung Trial run by the National Cancer Institute (NCI) (LMB-100,
Active, not recruiting
- Lung Cancer
- +2 more
- LMB-100
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 4, 2022
Tumors, Pancreatic Tumors Trial run by the NCI (LMB-100, Nab-Paclitaxel, Mesothelin Expression)
Completed
- Neoplasms
- Pancreatic Neoplasms
- LMB-100
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 16, 2022
Tumors With Mesothelin Expression, Epithelioid Mesothelioma, Cholangiocarcinoma, Extrahepatic Trial run by the NCI (LMB-100,
Active, not recruiting
- Neoplasms With Mesothelin Expression
- +3 more
- LMB-100
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 18, 2022
Mesothelioma Trial run by the NCI (LMB-100, Pembrolizumab)
Terminated
- Mesothelioma
- LMB-100
- Pembrolizumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 3, 2021
Mesothelioma Trial run by the NCI (LMB-100, SEL-110)
Terminated
- Mesothelioma
- LMB-100
- SEL-110
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 4, 2019